ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+1.27%(+0.011) 1D
Nov 13, 5:29:57 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
308.06M
Avg. vol.
739.90K
Volume
0.00
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
308.06M
Avg. vol.
739.90K
Volume
0.00
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
BigGo Finance
·
8 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
3 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
6 hours ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com